Yue Zhang

Dual-target CAR-T cells in triple-negative breast cancer: recent advances and translational challenges

Treatment options for triple-negative breast cancer (TNBC) remain extremely limited, and patients have a poor prognosis. Although chimeric antigen receptor (CAR)-T cell therapy has achieved breakthroughs in haematological malignancies, its application in solid tumours such as TNB...